Key Takeaways
- Shares of Cerebras plummeted approximately 14% in pre-market hours Wednesday following its inaugural earnings release as a public company
- First-quarter revenue hit $193 million, representing a 94% year-over-year surge and exceeding the Street’s $181 million forecast
- 2026 adjusted gross margin guidance of 38–41% fell short of expectations, trailing far behind Nvidia’s mid-70% margins
- Compressed margins result from Cerebras leasing back its own hardware to satisfy surging demand under its $20 billion OpenAI agreement
- Wall Street firms including Morgan Stanley, Wedbush, and TD Cowen lifted price objectives, with consensus analyst targets averaging $294
Shares of Cerebras Systems (CBRS) plunged approximately 14% during Wednesday’s pre-market session after the AI chip maker delivered its debut earnings report as a publicly traded entity. Trading at $226.72 at Tuesday’s close, the stock appeared headed for its lowest point since its May initial public offering, erasing over $6 billion in market capitalization.
The underlying financial performance looked solid on paper. First-quarter revenue totaled $193 million, marking a 94% jump from the prior-year period and surpassing analyst projections of $181 million. The company’s adjusted operating loss narrowed significantly to $3.5 million versus a $19.3 million deficit twelve months earlier. Second-quarter revenue projections of $194 million likewise exceeded the Street’s $178 million estimate.
What triggered the market’s negative reaction? The answer lies in profitability projections.
Cerebras issued 2026 adjusted gross margin guidance ranging from 38% to 41%, a notable decline from the 47% margin achieved during the first quarter. This trails considerably behind competitors — Nvidia operates with margins in the mid-70% territory, while AMD maintains mid-50% levels — despite exceeding the analyst consensus of 29.58%.
The Margin Compression Story
The profitability pressure connects directly to Cerebras’ massive $20 billion multi-year partnership with OpenAI. Customer demand from OpenAI has intensified beyond Cerebras’ capacity to activate new infrastructure. As a workaround, the semiconductor company is leasing back hardware previously sold to existing clients and reallocating those resources to OpenAI. This operational model generates lower profit margins.
Chief Executive Andrew Feldman revealed during the earnings conference call that OpenAI’s GPT 5.4 model is currently operating on Cerebras processors, and the artificial intelligence pioneer plans to implement 750 megawatts of its chip technology throughout the partnership. Feldman additionally disclosed that Amazon Web Services will integrate Cerebras semiconductors into its infrastructure, with monetization anticipated within twelve months.
A revenue recognition complexity adds another layer. Cerebras provided OpenAI with warrants covering 33.4 million shares at virtually no charge. As the partnership scales, these warrant values register as contra-revenue adjustments — non-cash reductions that lower reported top-line figures. Needham analyst Quinn Bolton identified this as an escalating challenge.
Customer Diversification Challenges Persist
Revenue concentration continues presenting risks. During the first quarter, 74% of total revenue originated from merely two sources: G42 and the Mohamed bin Zayed University of Artificial Intelligence — both affiliated with the United Arab Emirates government. OpenAI contributed an additional 9%. Combined, three customers represented 83% of quarterly sales.
The company’s $25 billion order backlog predominantly consists of the OpenAI contract. Management anticipates converting $4 billion of that pipeline into recognized revenue throughout the coming two years.
Notwithstanding the share price decline, Wall Street analysts maintained optimistic outlooks. Morgan Stanley elevated its price objective to $273 from $250. Wedbush increased its target to $280 from $270 while reaffirming an Outperform stance. TD Cowen highlighted the Amazon and OpenAI partnerships as fundamental drivers for sustained expansion. Across eleven initiating coverage firms, the mean analyst price target stands at $294 with a Buy recommendation.
One immediate technical consideration: a lockup period concludes Thursday, potentially releasing nearly 13% of IPO shares for sale by company insiders and early-stage investors.



